PORTFOLIO NEWS Twist Bioscience Announces Completion of $50 Million Registered Direct Offering Priced At-The-Market Jan 27, 2020 BlackThorn Therapeutics Advances Phase 2 Clinical Development for Selective KOR Antagonist, BTRX-140, in Neuropsychiatric Disorders Jan 23, 2020 Twist Bioscience Announces Strategic Collaboration With Schrödinger for Drug Discovery Jan 15, 2020 AiCure’s strategy of providing data for life sciences reinforced by record economic momentum Jan 14, 2020 Editas Medicine And Sandhill Therapeutics, Inc. Announce Collaboration To Develop Engineered Cell Medicines To Treat Cancer Jan 13, 2020 Omniome Closes $60 Million Series C Financing To Advance Novel Genomic Sequencing Platform Jan 9, 2020 Editas Medicine Strengthens Executive Leadership Team To Support Long-Term Growth Jan 9, 2020 Twist Bioscience and Pandion Therapeutics Expand Antibody Optimization Collaboration Dec 29, 2019 Thrive Earlier Detection Wins the BlueCross BlueShield Data Innovation Challenge Dec 17, 2019 GRAIL Appoints Gautam Kollu as Chief Commercial Officer Dec 16, 2019 « Older Entries Next Entries » PORTFOLIO PRESS COVERAGE Editas Medicine: A Good Proxy For The Gene Editing Space Sep 3, 2019 CNBC: Microsoft buys a start-up whose software limits access to sensitive data Jul 29, 2019 How One Company is Keeping data Secure in the Enterprise Jul 1, 2019 Dermatology News: Novel dermal coring device effective for facial rejuvenation without using thermal energy Jun 24, 2019 TechCrunch: Neurobehavioral health company BlackThorn pulls in $76 million from GV to treat mental disorders Jun 17, 2019 The Philadelphia Inquirer: 10-year-old’s cholesterol was over 800. Can CRISPR fix the problem? Jun 10, 2019 MDDI: Meet Thrive: The New Kid on the Liquid Biopsy Block Jun 6, 2019 The Hub at Johns Hopkins University: Early Cancer Detection Technology Receives Record Venture Investment Jun 3, 2019 Thrive’s Quest to Bring Multicancer Liquid Biopsy Test into Routine Clinical Use May 30, 2019 To Catch Early Cancer, and Rivals, Thrive Banks on Hopkins Blood Test May 30, 2019 « Older Entries Next Entries »
Twist Bioscience Announces Completion of $50 Million Registered Direct Offering Priced At-The-Market Jan 27, 2020
BlackThorn Therapeutics Advances Phase 2 Clinical Development for Selective KOR Antagonist, BTRX-140, in Neuropsychiatric Disorders Jan 23, 2020
AiCure’s strategy of providing data for life sciences reinforced by record economic momentum Jan 14, 2020
Editas Medicine And Sandhill Therapeutics, Inc. Announce Collaboration To Develop Engineered Cell Medicines To Treat Cancer Jan 13, 2020
Omniome Closes $60 Million Series C Financing To Advance Novel Genomic Sequencing Platform Jan 9, 2020
Dermatology News: Novel dermal coring device effective for facial rejuvenation without using thermal energy Jun 24, 2019
TechCrunch: Neurobehavioral health company BlackThorn pulls in $76 million from GV to treat mental disorders Jun 17, 2019
The Philadelphia Inquirer: 10-year-old’s cholesterol was over 800. Can CRISPR fix the problem? Jun 10, 2019
The Hub at Johns Hopkins University: Early Cancer Detection Technology Receives Record Venture Investment Jun 3, 2019
